|
|
|
ÄÞºñ·ÎÄÁ¤10/16mg Combirocan Tab. 10/16mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
|
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
Á¦Á¶È¸»ç |
ȯÀÎÁ¦¾à(ÁÖ)
|
ÆǸÅȸ»ç |
ȯÀÎÁ¦¾à(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2017.05.16)
|
BIT ¾àÈ¿ºÐ·ù |
°íÇ÷¾Ð Ä¡·áÁ¦ / °íÁöÇ÷Áõ Ä¡·áÁ¦ (Antihypertensives and Antilipidemic Agents)
|
º¹ÁöºÎºÐ·ù |
219[±âŸÀÇ ¼øȯ°è¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
657203110 \1,163 ¿ø/1Á¤(2020.01.01)(ÇöÀç¾à°¡)\1,164 ¿ø/1Á¤(2017.08.01)(º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Lipid modifying agents in combination with other drugs / C10BX |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
À¯´ç¼öȹ°,
ħ°Åº»êÄ®½·,
Ä«¸£³ª¿ì¹Ù³³,
Ä«¸£º¹½Ã¸ÞÆ¿¼¿·ê·Î¿À½ºÄ®½·,
Æú¸®¿¡Æ¿·»±Û¸®ÄÝ6000,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º
|
|
|
|
|
|
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-05-08 |
|
|
|
|
|
|
|
|